Teva Respiratory Announces Positive Results From Phase III Trial Of BDP HFA Nasal Aerosol In Seasonal Allergic Rhinitis
Teva Respiratory announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo...

Antarctic Octopus Venom Studied By Scientists
Researchers have collected venom from octopuses in Antarctica for the first time, significantly advancing our understanding of the properties of venom as a potential resource for drug-development...

Parents Of Students With Asthma And Allergies, How Do You Know When Your Child Is Ready To Self-Medicate At School?
Students with asthma and allergies will pack more than just a lunchbox and bookbag when they start school this year: They'll be devising ways to keep their life-saving medications close at hand should they need them. No longer do they have to be locked up in the nurse's cabinet or the office...

Ten Steps To A Safe School Year For Kids With Allergies And Asthma
For millions of children with allergies and asthma, heading back-to-school with high levels of fall pollens and molds in the air and exposure to potential allergens and viruses in class can really take a toll...

Extended Funding For Long-Standing Investigation Into Regulation Of Gastrointestinal Eosinophils
Marc E. Rothenberg, M.D., Ph.D., director of the Division of Allergy and Immunology at Cincinnati Children's, has received an NIH MERIT Award to extend funding of his long-standing investigation into "Regulation of Gastrointestinal Eosinophils." Dr...

Toxic Trio Identified As The Basis Of Celiac Disease
Walter and Eliza Hall Institute scientists have identified the three protein fragments that make gluten - the main protein in wheat, rye and barley - toxic to people with coeliac disease. Their discovery opens the way for a new generation of diagnostics, treatments, prevention strategies and food tests for the millions of people worldwide with coeliac disease...

Asthma And Eczema Sufferers Have A Lower Risk Of Developing A Cancer
Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRS Institut Armand-Frappier, the Research Centre of the Centre hospitalier de l'Université de Montréal, and McGill University...

What Protects Farm Children From Hay Fever, The Protective Substance Slumbers In Cowshed Dust
Researchers from Bochum have isolated the substance in cowshed dust that possibly protects farm children from developing allergies and allergic asthma, namely the plant sugar molecule arabinogalactan. If high concentrations thereof are inhaled during the first year of life it inhibits the immune system from excessive defense reactions...

Early Exposure To Milk Protein From Cows Increases Allergy Resistance Later In Life
Many doctors suggest that whole cow's milk be avoided in the early months of an infant's feeding. Lactation specialists go even further, counseling "mother's milk only" until baby starts eating solid food. But new research from Tel Aviv University says that mothers who feed their babies cow's milk in the first 15 days of life may be protecting their children from dangerous allergies later on...

Consortium Of Food Allergy Research Renewed With A Five-Year, $29.9 Million Grant
The National Institutes of Health has announced that the Consortium of Food Allergy Research (CoFAR), established in 2005, will be funded for five more years...

Long Term Cognitive Impairment Of Aging Brain Caused By Medications
Drugs commonly taken for a variety of common medical conditions including insomnia, allergies, or incontinence negatively affect the brain causing long term cognitive impairment in older African-Americans, according to a study appearing in the July 13, 2010 print issue of Neurology, the medical journal of the American Academy of Neurology...

DBV Technologies Receives IND Clearance From FDA To Begin Clinical Trial In Peanut Allergy
DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application...

Genetic Regulator Opens New Avenues To AIDS, Immune System Research
Researchers at Oregon State University and the California Institute of Technology have discovered that a genetic regulator which is critical to many life functions also plays a key role in the formation of "T cells," a type of white blood cell that's important in immune function...

UCLA-Led Study Has Implications For Traffic-Related Asthma Flares
A new academic study led by UCLA scientists has found that even brief exposure to ultrafine pollution particles near a Los Angeles freeway is potent enough to boost the allergic inflammation that exacerbates asthma...

Sepracor Reports Preliminary Results From A Second Phase III Study For OMNARIS(R) HFA Nasal Aerosol In Seasonal Allergic Rhinitis
Sepracor Inc. announced the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients...